Document:

Exhibit 10.02

 

PURCHASE AGREEMENT

 

       THIS
PURCHASE AGREEMENT (“Agreement”) is made as of the 14th day of January, 2016, by and between H-Cell Energy
Corporation, a Nevada corporation (the “Company”), and _________________ (the “Investor”).

 

Recitals

 

A.        The
Company and the Investor are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by the provisions of Regulation D (“Regulation D”), as promulgated by the U.S. Securities and Exchange
Commission (the “SEC”) under Securities Act; and

 

B.         The
Investor wishes to purchase from the Company, and the Company wishes to sell and issue to the Investor, upon the terms and conditions
stated in this Agreement, 526,316 shares of the Company’s Common Stock (the “Shares”) for $200,000 (the
“Purchase Price”).

 

In
consideration of the mutual promises made herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:

 

1.             Definitions.
In addition to those terms defined above and elsewhere in this Agreement, for the purposes of this Agreement, the following terms
shall have the meanings set forth below:

 

“Affiliate”
means, with respect to any Person, any other Person which directly or indirectly through one or more intermediaries Controls, is
controlled by, or is under common control with, such Person.

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction
of business.

 

“Closing”
and “Closings” have the meaning set forth in Section 3.

 

“Closing
Date” has the meaning set forth in Section 3.

 

“Common
Stock” means common stock of the Company.

 

“Control”
(including the terms “controlling”, “controlled by” or “under common control with”) means the
possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether
through the ownership of voting securities, by contract or otherwise.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.

 

     

     

    

 

“Material
Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of operations, condition (financial
or otherwise), business, or prospects of the Company and its Subsidiaries taken as a whole, or (ii) the ability of the Company
to perform its obligations under this Agreement.

 

“Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically
listed herein.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.

 

2.              Purchase
and Issuance of the Shares

 

2.1       Shares.
Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6.1 and 6.2 below, the Company shall issue and
sell to the Investor, and the Investor shall purchase from the Company on the Closing Date (as defined below), the Shares.

 

3.              Closing.
The closing (“Closing”) of the purchase of the Shares by the Investor as contemplated by this Agreement shall
occur at the offices of Sichenzia Ross Friedman Ference LLP, 61 Broadway, 32nd Floor, New York, New York 10006. The
date and time of the Closing (the “Closing Date”) shall be 10:00 a.m., New York time, on such date as is mutually
agreed to by the Company and the Investor. On or prior to the Closing Date, the Investor shall have delivered to the Company an
amount representing the Purchase Price, plus expenses as set forth herein.

 

4.             Representations
and Warranties of the Company. The Company hereby represents and warrants to the Investor that:

 

4.1           Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to carry on its business as now
conducted and to own its properties. The Company is duly qualified to do business as a foreign corporation and is in good standing
in each jurisdiction in which the conduct of its business or its ownership or leasing of property makes such qualification or leasing
necessary unless the failure to so qualify has not had and could not reasonably be expected to have a Material Adverse Effect.

 

4.2           Authorization.
The Company has full power and authority and has taken all requisite action on the part of the Company, its officers, directors
and stockholders necessary for (i) the authorization, execution and delivery of this Agreement, (ii) the authorization of the performance
of all obligations of the Company hereunder or thereunder, and (iii) the authorization, issuance and delivery of the Shares.
This Agreement constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general
applicability, relating to or affecting creditors’ rights generally.

 

    	 	-2-	 

     

    

 

4.3           Valid
Issuance. The Shares have been duly and validly authorized and, when issued and paid for pursuant to this Agreement, will be
validly issued, fully paid and nonassessable, and shall be free and clear of all encumbrances and restrictions (other than those
created by the Investor), except for restrictions on transfer set forth in this Agreement or imposed by applicable securities laws.

 

4.4           Consents.
The execution, delivery and performance by the Company of this
Agreement and the offer, issuance and sale of the Shares require no consent of, action by or in respect of, or filing with, any
Person, governmental body, agency, or official other than filings that have been made pursuant to applicable state securities laws
and post-sale filings pursuant to applicable state and federal securities laws which the Company undertakes to file within the
applicable time periods. Subject to the accuracy of the representations and warranties of the Investor set forth in Section 5 hereof,
the Company has taken all action necessary to exempt (i) the issuance and sale of the Shares and (ii) the other transactions contemplated
by this Agreement from the provisions of any stockholder rights plan or other “poison pill” arrangement, any anti-takeover,
business combination or control share law or statute binding on the Company or to which the Company or any of its assets and properties
may be subject and any provision of the Company’s Articles of Incorporation, Bylaws or other organizational or charter documents
that is or could reasonably be expected to become applicable to the Investor as a result of the transactions contemplated hereby,
including without limitation, the issuance of the Shares and the ownership, disposition or voting of the Shares by the Investor
or the exercise of any right granted to the Investor pursuant to this Agreement.

 

4.5           Use
of Proceeds. The net proceeds of the sale of the Shares hereunder shall be used by the Company for working capital purposes.

 

4.6           No
Conflict, Breach, Violation or Default. The execution, delivery and performance of this Agreement by the Company and the issuance
and sale of the Shares will not conflict with or result in a breach or violation of any of the terms and provisions of, or constitute
a default under (i) the Company’s Articles of Incorporation, the Company’s Bylaws or other organizational or charter
documents, as in effect on the date hereof, or (ii)(a) any statute, rule, regulation or order of any governmental agency or body
or any court, domestic or foreign, having jurisdiction over the Company or any of its assets or properties, or (b) any agreement
or instrument to which the Company is a party or by which the Company is bound or to which any of its assets or properties is subject.

 

4.7           Brokers
and Finders. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest
or claim against or upon the Company or the Investor for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Company.

 

4.8           No
General Solicitation. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or
sale of the Shares.

 

    	 	-3-	 

     

    

 

4.9           No
Integrated Offering. Neither the Company nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances
that would adversely affect reliance by the Company on Regulation D for the exemption from registration for the transactions contemplated
hereby or would require registration of the Shares under the Securities Act.

 

4.10         Private
Placement. Assuming the representations and warranties of the Investor are true, the offer and sale of the Shares to the Investor
as contemplated hereby is exempt from the registration requirements of the Securities Act.

 

4.11         Capitalization.
As of the date of this Agreement, the authorized capital stock of the Company consists of 30,000,000 shares of Common Stock, of
which, 2,105,263 are issued and outstanding and no shares are reserved for issuance. No shares of Common Stock are held in treasury.
All of such outstanding shares are duly authorized and have been validly issued and are fully paid and non-assessable.

 

5.             Representations
and Warranties of the Investor. The Investor hereby represents and warrants as of the date hereof to the Company as follows:

 

5.1           Organization,
Good Standing and Qualification. The Investor is a corporation duly organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to carry on its business
as now conducted and to own its properties and purchase the Shares.

 

5.2           Authorization.
The execution, delivery and performance by the Investor of this Agreement has been duly authorized and will constitute the legal,
valid and binding obligation of the Investor, enforceable against the Investor in accordance with its respective terms, subject
to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating
to or affecting creditors’ rights generally.

 

5.3           No
Public Sale or Distribution. The Investor is acquiring the Shares for its own account and not with a view towards, or for resale
in connection with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant to sales
registered or exempted under the Securities Act; provided, however, by making the representations herein, such Investor does not
agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the
right to dispose of the Shares at any time in accordance with or pursuant to a registration statement or an exemption under the
Securities Act. The Investor is acquiring the Shares hereunder in the ordinary course of its business. Such Investor does not presently
have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Shares in violation of applicable
securities laws. Investor is not a broker-dealer registered with the SEC under the Exchange Act or an entity engaged in a business
that would require it to be so registered.

 

    	 	-4-	 

     

    

 

5.4           Investment
Experience. Investor acknowledges that it can bear the economic risk and complete loss of its investment in the Shares and
has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the
investment contemplated hereby.

 

5.5           Disclosure
of Information. The Investor and its advisors, if any, have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and sale of the Shares that have been requested by the Investor.
The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. The Investor understands
that its investment in the Shares involves a high degree of risk. The Investor has sought such accounting, legal and tax advice
as he has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.

 

5.6           Restricted
Securities. Investor understands that the Shares are characterized as “restricted securities” under the U.S. federal
securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that
under such laws and applicable regulations such securities may be resold without registration under the Securities Act only in
certain limited circumstances. The Investor understands that the Shares are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
in part upon the truth and accuracy of, and Investor’s compliance with, the representations, warranties, agreements, acknowledgments
and understanding of Investor set forth herein in order to determine the availability of such exemptions and the eligibility of
Investor to acquire such securities.

 

5.7           Legends.
It is understood that, except as provided below, certificates evidencing the Shares may bear the following or any similar legend:

 

(a)         “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER
(IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.”

 

(b)         If
required by the authorities of any state in connection with the issuance of sale of the Shares, the legend required by such state
authority.

 

    	 	-5-	 

     

    

 

5.8           No
Governmental Review. The Investor understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in
the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Shares.

 

5.9           Transfer
or Resale. The Investor understands that: (i) the Shares have not been and are not being registered under the Securities Act
or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered
thereunder, (B) the Investor shall have delivered to the Company (if requested by the Company) an opinion of counsel to the Investor,
in a form reasonably acceptable to the Company, to the effect that such Shares to be sold, assigned or transferred may be sold,
assigned or transferred pursuant to an exemption from such registration, or (C) the Investor provides the Company with reasonable
assurance that such Shares can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the Securities
Act (or a successor rule thereto) (collectively, “Rule 144”); (ii) any sale of the Shares made in reliance on
Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of the
Shares under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter
(as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the
rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under any obligation
to register the Shares under the Securities Act or any state securities laws or to comply with the terms and conditions of any
exemption thereunder.

 

5.10         Brokers
and Finders. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest
or claim against or upon the Company or the Investor for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Investor.

 

5.11         Accredited
Investor Status. The Investor is an “accredited investor” as that term is defined in Rule 501(a) of Regulation
D.

 

5.12         Risk
Factors. The investment described herein involves a very high degree of risk and speculation and has the potential to result
in a one hundred percent (100%) loss without an effective legal remedy or recourse due to the nature of the investment.  The
Investor agrees to be entirely responsible for its own due diligence as to the veracity, accuracy or prospects of the Company or
the safety of the investment. The Investor cannot rely on any matter or representation made by the Company or any other
party relating to this investment, and shall be accountable for completing its own analysis and review of the risks, representations
and warranties of the Company or any party assisting or otherwise advising the Company or the Investor in this matter.

 

5.13         Residency.
The Investor is a resident of the State of New Jersey.

 

    	 	-6-	 

     

    

 

6.
Conditions to Closing.

 

6.1           Conditions
to the Investor’s Obligations. The obligation of the Investor to purchase the Shares at the Closing is subject to the
fulfillment to the Investor’s satisfaction, on or prior to the Closing Date, of the following conditions, any of which may
be waived by the Investor:

 

(a)       The
representations and warranties made by the Company in Section 4 hereof qualified as to materiality shall be true and correct at
all times prior to and on the Closing Date, except to the extent any such representation or warranty expressly speaks as of an
earlier date, in which case such representation or warranty shall be true and correct as of such earlier date, and, the representations
and warranties made by the Company in Section 4 hereof not qualified as to materiality shall be true and correct in all material
respects at all times prior to and on the Closing Date, except to the extent any such representation or warranty expressly speaks
as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of such
earlier date. The Company shall have performed in all material respects all obligations and covenants herein required to be performed
by it on or prior to the Closing Date.

 

(b)       No
judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any bankruptcy
court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have
been instituted by any governmental authority, enjoining or preventing the consummation of the transactions contemplated in this
Agreement.

 

(c)       The
Company shall have delivered this executed Agreement to the Investor.

 

6.2           Conditions
to Obligations of the Company. The Company's obligation to sell and issue the Shares at the Closing is subject to the fulfillment
to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the
Company:

 

(a)       The
representations and warranties made by the Investor in Sections 5.1 and 5.2 hereof (the “Investment Representations”),
shall be true and correct in all material respects when made, and shall be true and correct in all material respects on the Closing
Date with the same force and effect as if they had been made on and as of said date. The Investment Representations shall be true
and correct in all respects when made, and shall be true and correct in all respects on the Closing Date with the same force and
effect as if they had been made on and as of said date. The Investor shall have performed in all material respects all obligations
and covenants herein required to be performed prior to the Closing Date.

 

(b)       The
Investor shall have delivered the Purchase Price to the Company.

 

    	 	-7-	 

     

    

 

(c)       The
Investor shall have delivered this executed Agreement to the Company.

 

(d)       The
Investor shall have reimbursed the Company for all costs and expenses incurred by it (including, without limitation, all legal
fees and disbursements in connection therewith, structuring, documentation and implementation of the transactions contemplated
by this Agreement and due diligence and regulatory filings in connection therewith) in a non-accountable amount equal to $2,000.

 

6.3           Termination.
In the event that the Closing shall not have occurred by February 15, 2016, then at the close of business on such date the parties’
obligations hereunder to consummate the Closing shall automatically terminate without further liability of the parties to one another
solely in respect thereof. Notwithstanding anything to the contrary above, nothing contained in this Section 6.3 shall be deemed
to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or to impair
the right of any party to compel specific performance by any other party of its obligations under this Agreement.

 

7.              Covenants
and Agreements of the Company.

 

7.1           Delivery
of Shares. The Company shall, within 15 Business Days of the Closing Date, delivery the Shares to the Investor.

 

7.2           No
Conflicting Agreements. The Company will not take any action, enter into any agreement or make any commitment that would conflict
or interfere in any material respect with the Company’s obligations to the Investor under this Agreement.

 

7.3           Compliance
with Laws. The Company will comply in all material respects with all applicable laws, rules, regulations, orders and decrees
of all governmental authorities.

 

7.4           Board
Appointment. Upon Closing, the Company shall appoint Rezaul Karim to the Company’s board of directors.

 

8.             Survival.

 

8.1           Survival. The representations, warranties, covenants and agreements contained in this Agreement shall survive each Closing
of the transactions contemplated by this Agreement.

 

9.             Miscellaneous.

 

9.1           Successors
and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the Company or the Investor,
as applicable, which consent may be withheld in such parties absolute discretion. The provisions of this Agreement shall inure
to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement,
express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

    	 	-8-	 

     

    

 

9.2           Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that
any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an
executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

9.3           Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

 

9.4           Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered: (i) upon receipt, if delivered personally; and (ii) if sent by overnight
courier service, one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The addresses for such notices, consents, waivers or other communications
are as follows:

 

If
to the Company:

 

H-Cell Energy Corporation

97 River Road

Flemington, New Jersey 08822

Attention: Andrew Hidalgo, Chief
Executive Officer

 

With
a copy to:

 

Sichenzia Ross Friedman Ference
LLP

61 Broadway, 32nd Floor

New York, New York 10006

Attention:
Thomas A. Rose, Esq./James M. Turner, Esq.

 

If
to the Investor, to the address set forth on the signature page.

 

or to such other address and/or to the
attention of such other Person as the recipient party has specified by written notice given to each other party five (5) days prior
to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver
or other communication, or (B) provided by an overnight courier service shall be rebuttable evidence of personal service or receipt
from an overnight courier service in accordance with clause (i) or (ii) above, respectively.

 

    	 	-9-	 

     

    

 

9.5           Amendments
and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company
and the Investor. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each holder of any Shares
purchased under this Agreement at the time outstanding, each future holder of all such Shares, and the Company.

 

9.6           Severability.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted
as if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted
by applicable law, the parties hereby waive any provision of law which renders any provision hereof prohibited or unenforceable
in any respect.

 

9.7           Entire
Agreement. This Agreement constitutes the entire agreement among the parties hereof with respect to the subject matter hereof
and thereof and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the
subject matter hereof and thereof.

 

9.8           Further
Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other actions
as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements
herein contained.

 

9.9           Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with,
the internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District
Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising
out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or
proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices
under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action
or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue
of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding
brought in any such court has been brought in an inconvenient forum.  EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST
A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS
TO THIS WAIVER.

 

(Signature Pages Follow)

 

    	 	-10-	 

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized officers to execute this Agreement as
of the date first above written.

 

	The Company:  	H/CELL ENERGY CORPORATION
	 	 
	 	By:	 
	 	Name:	Andrew Hidalgo
	 	Title:	Chief Executive Officer

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR INVESTOR FOLLOWS]

 

     

     

    

 

[INVESTOR
SIGNATURE PAGE TO H/CELL ENERGY PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF,
the undersigned have caused this Purchase Agreement to be duly executed by their respective authorized signatories as of the date
first indicated above.

 

	Name of Investor:	 
	 	 
	By:	 	 
	Name:	 
	Title:	 

 

Address for Notice of Investor:Exhibit
10.03

 

THIS SUBSCRIPTION AGREEMENT IS EXECUTED
IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION 4(a)(2) AND REGULATION D, RULE 506 FOR TRANSACTIONS NOT INVOLVING A PUBLIC OFFERING
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS OFFERING IS BEING MADE ONLY TO ACCREDITED
INVESTORS. NONE OF THE SECURITIES TO WHICH THIS SUBSCRIPTION RELATES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT, OR ANY U.S.
STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, EXCEPT IN ACCORDANCE WITH
THE PROVISIONS OF REGULATION D UNDER THE SECURITIES ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT,
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE
SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE SECURITIES ACT.

_________________________

 

SUBSCRIPTION AGREEMENT

_________________________

 

THIS SUBSCRIPTION AGREEMENT (this
“Subscription”) has been executed by H/Cell Energy Corporation, a corporation organized under the laws of the State
of Nevada (hereinafter referred to as the “Company”) and the purchaser set forth in the Signature Page (the “Signature
Page”) attached hereto (the “Purchaser”) in connection with the private placement of up to a maximum of 500,000
shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”)
at a purchase price of $0.50 per Share. The Shares being subscribed for pursuant to this Subscription has not been registered under
the Securities Act. The offer of the Shares and, if this Subscription is accepted by the Company, the sale of the Shares, is being
made in reliance upon Section 4(a)(2) and/or Rule 506 of Regulation D promulgated under the Securities Act. All dollar amounts
in this Subscription are expressed in U.S. Dollars.

 

The Shares will be offered in a minimum
principal amount of $1,500. The Company reserves the right, in its discretion, to accept subscriptions for lesser amounts.

 

This Subscription is submitted by the undersigned
in accordance with and subject to the terms and conditions described in this Subscription, the Confidential Private Placement Memorandum
of the Company dated on or about March 21, 2016, as amended and supplemented from time to time, including all attachments, schedules
and exhibits thereto (the “Memorandum”).

 

The terms of the offering of the Shares
(“Offering”) are more completely described in the Memorandum and such terms are incorporated herein in their entirety.

 

The Purchaser hereby
represents and warrants to, and agrees with the Company as follows:

 

     

     

    

  

ARTICLE 1

SUBSCRIPTION

 

Subscription

 

1.1           The
undersigned Purchaser, as principal, hereby subscribes to purchase the number of Shares set forth on the Signature Page
attached hereto, at $0.50 per Share, for an aggregate purchase price as set forth on the Signature Page (the “Subscription
Funds”).

 

Minimum
Subscription

 

1.2           A
minimum of $1,500 of Shares must be purchased by the Purchaser, unless a lower amount is agreed to by the Company, in its sole
discretion.

 

Method of
Payment

 

1.3           The
Purchaser shall pay the Subscription Funds by delivering good funds in United States Dollars by way of wire transfer of funds to
Sichenzia Ross Friedman Ference LLP, the escrow agent for this Offering (“Escrow Agent”). The wire transfer instructions
are as set forth in Exhibit B, attached hereto and made a part hereof.

 

Upon receipt of the
Subscription Funds and acceptance of this Subscription by the Company, the Company shall take up the Subscription Funds (the “Closing
Date”) and issue to the Purchaser such number of shares of Common Stock represented by the amount of the accepted Subscription
Funds. The Purchaser and the Company acknowledge and agree that the initial closing of the Offering shall be at the Company’s
discretion.

 

The Purchaser acknowledges
that the subscription for Shares hereunder may be rejected in whole or in part by the Company in its sole discretion and for any
reason, notwithstanding prior receipt by the Purchaser of notice of acceptance of such subscription. The Company shall have no
obligation hereunder until the Company shall execute and deliver to the Purchaser an executed copy of this Subscription. If this
Subscription is rejected in whole, or the offering of Shares is terminated, all funds received from the Purchaser will be returned
without interest or offset, and this Subscription shall thereafter be of no further force or effect. If this Subscription is rejected
in part, the funds for the rejected portion of this subscription will be returned without interest or offset, and this Subscription
will continue in full force and effect to the extent this Subscription was accepted.

 

Term; Termination

 

1.4           All
funds received from the Purchaser will held in a non-interest-bearing escrow account by the Escrow Agent, pending the earlier of
(a) one or more closings, (b) completion of the Maximum Offering or (c) June 30, 2016, which may be extended to August 31, 2016
by the Company in its sole discretion (the “Offering Period”), unless the Offering is earlier terminated by the Company.
All funds received from the Purchaser that are not closed upon during the Offering Period will be returned without interest or
offset, and this Subscription shall thereafter be of no further force or effect.

 

    	2 

     

    

  

ARTICLE
2

REPRESENTATIONS
AND WARRANTIES OF THE PURCHASER

 

Representations
and Warranties

 

2.1           The
Purchaser represents and warrants to the Company, with the intent that the Company will rely thereon in accepting this Subscription,
that:

 

(a)   Accredited
Investor. The Purchaser is an “accredited investor” as that term is defined in Regulation D promulgated under the
Securities Act and as set forth in the Investor Questionnaire attached hereto as Exhibit A and made a part hereof;

 

(b)   Experience.
The Purchaser is sufficiently experienced in financial and business matters to be capable of evaluating the merits and risks of
its investments, and to make an informed decision relating thereto, and to protect its own interests in connection with the purchase
of the Shares;

 

(c)   Own
Account. The Purchaser is purchasing the Shares as principal for its own account. The Purchaser is purchasing the Shares for
investment purposes only and not with an intent or view towards further sale or distribution (as such term is used in Section 2(11)
of the Securities Act) thereof, and has not pre-arranged any sale with any other purchaser and has no plans to enter into any such
agreement or arrangement;

 

(d)   Exemption.
The Purchaser understands that the offer and sale of the Shares is not being registered under the Securities Act or any state securities
laws and is intended to be exempt from registration provided by Rule 506 promulgated under Regulation D and/or Section 4(a)(2)
of the Securities Act;

 

(e)   Importance
of Representations. The Purchaser understands that the Shares are being offered and sold to it in reliance on an exemption
from the registration requirements of the Securities Act, and that the Company is relying upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of the Purchaser set forth herein in order to determine the applicability
of such safe harbor and the suitability of the Purchaser to acquire the Shares;

 

(f)   No
Registration. The Shares have not been registered under the Securities Act or any state securities laws and may not be transferred,
sold, assigned, hypothecated or otherwise disposed of unless registered under the Securities Act and applicable state securities
laws or unless an exemption from such registration is available (including, without limitation, under Rule 144 of the Securities
Act, as such rule may be amended, or any similar rule or regulation hereafter adopted by the Commission having substantially the
same effect (“Rule 144”)). The Purchaser represents and warrants and hereby agrees that all offers and sales of the
Shares shall be made only pursuant to such registration or to such exemption from registration;

 

    	3 

     

    

 

(g)   Risk.
The Purchaser acknowledges that the purchase of the Shares involves a high degree of risk, is aware of the risks and further acknowledges
that it can bear the economic risk of the Shares, including the total loss of its investment. The Purchaser has adequate means
of providing for its financial needs and foreseeable contingencies and has no need for liquidity of its investment in the Shares
for an indefinite period of time;

 

(h)   Memorandum.
The Purchaser has received the Memorandum and all other documents requested by the Purchaser, have carefully reviewed them and
understand the information contained therein;

 

(i)   Independent
Investigation. The Purchaser, in making the decision to purchase the Shares subscribed for, has relied upon independent investigations
made by it, and the Purchaser has prior to any sale to it been given access and the opportunity to examine all material contracts
and documents relating to this Offering and an opportunity to ask questions of, and to receive answers from, the Company or any
person acting on its behalf concerning the terms and conditions of this Offering. The Purchaser and its advisors, if any, have
been furnished with access to all materials relating to the business, finances and operation of the Company and materials relating
to the offer and sale of the Shares (including, without limitation, the Memorandum) which have been requested. The Purchaser and
its advisors, if any, have received complete and satisfactory answers to any such inquiries;

 

(j)   No
Recommendation or Endorsement. The Purchaser understands that no federal, state or other regulatory authority has passed on
or made any recommendation or endorsement of the Shares. Furthermore, the foregoing authorities have not confirmed the accuracy
or determined the adequacy of this Subscription or the Memorandum. Any representation to the contrary is a criminal offense;

 

(k)   No
Representation. In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation
or information (oral or written) other than as stated in this Subscription and in the Memorandum;

 

(l)   No
Tax, Legal, Etc. Advise. The Purchaser is not relying on the Company or any of its employees or agents with respect to the
legal, tax, economic and related considerations of an investment in the Shares, and the Purchaser has relied on the advice of,
or has consulted with, only its own advisers;

 

    	4 

     

    

  

(m)   The
Purchaser. The Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power
and authority to execute and deliver this Subscription and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Shares, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Subscription and all other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase
and hold the Shares, the execution and delivery of this Subscription has been duly authorized by all necessary action, this Subscription
has been duly executed and delivered on behalf of such entity and is a legal, valid and binding obligation of such entity; or (iii)
if executing this Subscription in a representative or fiduciary capacity, represents that it has full power and authority to execute
and deliver this Subscription in such capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation,
or limited liability company or partnership, or other entity for whom the Purchaser is executing this Subscription, and such individual,
partnership, ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and
power to perform pursuant to this Subscription and make an investment in the Company, and represents that this Subscription constitutes
a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription will not violate or be in
conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is a party or by which
it is bound; and

 

(n)   No
Advertisement or General Solicitation. Purchaser acknowledges that it is not aware of, is in no way relying on, and did not
become aware of the offering of the Shares through or as a result of any form of general solicitation or general advertising, including,
without limitation, any article, notice, advertisement or other communication published in any newspaper, magazine, or similar
media or broadcast over television or radio, or through any seminar or meeting whose attendees have been invited by any general
solicitation or general advertising.

 

Survival

 

2.2           The
representations and warranties of the Purchaser contained herein will be true at the date of execution of this Subscription by
the Purchaser and as of the Closing Date in all material respects as though such representations and warranties were made as of
such times and shall survive the Closing Date and the delivery of the Shares. The Purchaser agrees that it will notify and supply
corrective information to the Company immediately upon the occurrence of any change therein occurring prior to the Company’s
issuance of the Shares.

 

    	5 

     

    

  

ARTICLE 3

REPRESENTATIONS AND
WARRANTIES OF THE COMPANY

 

3.1           The
Company, upon taking up and accepting this Subscription, represents and warrants in all material respects to the Purchaser, with
the intent that the Purchaser will rely thereon in making this Subscription, that:

 

		(a)	Legality. The Company has the requisite corporate power and authority to take up and accept
this Subscription and to issue, sell and deliver the Shares; this Subscription and the issuance, sale and delivery of the Shares
hereunder and the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action by the
Company; this Subscription and the Shares have been duly and validly executed and delivered by and on behalf of the Company, and
are valid and binding agreements of the Company, enforceable in accordance with their respective terms, except as enforceability
may be limited by general equitable principles, bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, or other
laws affecting creditors’ rights generally;

 

		(b)	Proper Organization. The Company is a corporation duly organized, validly existing and in
good standing under the laws of its jurisdiction of incorporation;

 

		(c)	No Legal Proceedings. There is no action, suit or proceeding before or by any court or any
governmental agency or body, domestic or foreign, now pending or to the knowledge of the Company, threatened, against or affecting
the Company or its Subsidiaries, or any of their properties or assets, which might result in (i) a material adverse effect on the
legality, validity or enforceability of this Subscription or the Shares (collectively, the “Transaction Documents”),
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and its Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform
in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”);

 

		(d)	Non-Contravention. The acceptance of this Subscription and the consummation of the issuance
of the Shares and the transactions contemplated by this Subscription do not and will not conflict with or result in a breach by
the Company of any of the terms or provisions of, or constitute a default under the Articles of Incorporation or Bylaws of the
Company, or any indenture, mortgage, deed of trust, or other material agreement or instrument to which the Company or any of its
Subsidiaries is a party or by which it or any of its properties or assets are bound, or any existing applicable decrees, judgment
or order of any court, federal, state or provincial regulatory body, administrative agency or other domestic governmental body
having jurisdiction over the Company or any of its properties or assets;

 

    	6 

     

    

  

		(e)	Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local
or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of this
Subscription, other than the filing of Form D with the Commission and such filings as are required to be made under applicable
state securities laws;

 

		(f)	Issuance of the Shares. The Shares are duly authorized and, when issued and paid for in
accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear
of all liens, charges, security interests, encumbrances, preemptive rights or other restrictions (collectively, “Liens”)
imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Shares, when issued in
accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents;

 

		(g)	Title to Assets. The Company and its Subsidiaries have good and marketable title to the
leasehold interest owned by it and good and marketable title in all personal property owned by it that is material to the business
of the Company in each case free and clear of all Liens, except for Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and Liens for the payment
of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties; and

 

		(h)	No General Solicitation. Neither the Company nor any person acting on behalf of the Company
has offered or sold any of the Shares by any form of general solicitation or general advertising.

 

Survival

 

3.2           The
representations and warranties of the Company will be true and correct as of the Closing Date in all material respects and shall
survive the Closing Date and the delivery of the Shares.

 

ARTICLE 4

COVENANTS OF THE COMPANY

 

Covenants of the Company

 

4.1           The
Company covenants and agrees with the Purchaser that:

 

		(a)	Filings. The Company shall make all necessary filings in connection with the sale of the
Shares as required by the laws and regulations of all appropriate jurisdictions and securities exchanges, including but not limited
to “Form D” and “blue sky” filings;

 

    	7 

     

    

  

		(b)	Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or
sale of the Shares in a manner that would require the registration under the Securities Act of the sale of the Shares to the Purchasers;
and

 

		(c)	Non-Public Information. Except with respect to the material terms and conditions of the
transactions contemplated by the Transaction Documents, the Company covenants and agrees that neither it nor any other Person acting
on its behalf, will provide any Purchaser or its agents or counsel with any information that the Company believes constitutes material
non-public information, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality
and use of such information. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.

 

Survival

 

4.2           The
covenants set forth in this Article shall survive the Closing Date for the benefit of the Purchaser.

 

ARTICLE 5

ISSUANCE OF SECURITIES

 

5.1           As
soon as practicable after the Closing Date, the Company shall issue and deliver, or shall cause the issuance and delivery of, the
Shares in the name or names specified by the Purchaser purchased in the Offering. Such Shares shall bear a legend in substantially
the following form:

 

THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED
BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS
SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

    	8 

     

    

  

5.2           The
legend set forth above shall be removed, and the Company shall issue a certificate without such legend to the transferee of the
Shares represented thereby, if, unless otherwise required by state securities laws, (i) such Shares have been sold under an effective
registration statement under the Securities Act, (ii) such Shares have been sold pursuant to a valid exemption under the Securities
Act or (iii) such legend is not required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission). The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 5.

 

ARTICLE 6

CLOSING

 

Closing shall be effected
through the delivery of the Subscription Funds by the Escrow Agent to the Company and the delivery of the Shares purchased in the
Offering by the Company to the Purchaser, together with a copy of this Subscription Agreement, duly executed, which the Purchaser
acknowledges will be both be delivered after the Closing.

 

ARTICLE 7

INDEMNIFICATION

 

Indemnification of the Company

 

7.1           The
Purchaser agrees to indemnify and hold harmless the Company against and in respect of any and all loss, liability, claim, damage,
deficiency, and all actions, suits, proceedings, demands, assessments, judgments, costs and expenses whatsoever (including, but
not limited to, attorneys' fees reasonably incurred in investigating, preparing, or defending against any litigation commenced
or threatened or any claim whatsoever through all appeals) arising out of or based upon any false representation or warranty or
breach or failure by the Purchaser to comply with any covenant, representation or other provision made by it herein or in any other
document furnished by it in connection with this Subscription, provided, however, that such indemnity, shall in no event exceed
the net proceeds received by the Company from the Purchaser as a result of the sale of Shares to the Purchaser.

 

Indemnification of the Purchaser

 

7.2           The
Company agrees to indemnify and hold harmless the Purchaser against and in respect of any and all loss, liability, claim, damage,
deficiency, and all actions, suits, proceedings, demands, assessments, judgments, costs and expenses whatsoever (including, but
not limited to, attorneys' fees reasonably incurred in investigating, preparing, or defending against any litigation commenced
or threatened or any claim whatsoever through all appeals) arising out of or based upon any false representation or warranty or
breach or failure by the Company to comply with any covenant, representation or other provision made by it herein or in any other
document furnished by it in connection with this Subscription.

 

    	9 

     

    

  

ARTICLE 8

GENERAL PROVISIONS

 

Governing Law

 

8.1           This
Subscription shall be governed by and construed under the law of the State of New York without regard to its choice of law provision.
Any disputes arising out of, in connection with, or with respect to this Subscription, the subject matter hereof, the performance
or non-performance of any obligation hereunder, or any of the transactions contemplated hereby shall be adjudicated in a court
of competent civil jurisdiction sitting in New York, New York and nowhere else. The parties hereby consent to the service of process
in any such action or legal proceeding by means of registered or certified mail, return receipt requested. The address for service
of process shall be (a) to the Company, at H/Cell Energy Corporation, 97 River Road, Flemington, NJ 08822, Attn: CEO, and (b) to
the Purchaser, at the address set forth on the Signature Page hereto, or, in each case, to such other address as each party shall
subsequently furnish in writing to the other. In any action, suit or proceeding brought by any party against any other party,
the parties each knowingly and intentionally, to the greatest extent permitted by applicable law, hereby absolutely, unconditionally,
irrevocably and expressly waive forever trial by jury.

 

Successors and Assigns

 

8.2           This
Subscription shall inure to the benefit of and be binding on the respective successors and assigns of the parties hereto.

 

Execution by Counterparts

 

8.3           This
Subscription may be executed in two or more identical counterparts, all of which shall be considered one and the same Subscription
and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that
any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an
executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

Independent Legal Advice

 

8.4           Each
Purchaser has been represented by its own separate legal counsel in connection with the transactions contemplated hereby, or has
knowingly and willingly elected not to do so, and acknowledges and understands that Sichenzia Ross Friedman Ference LLP has served
as counsel to the Company only.

 

    	10 

     

    

  

Severability

 

8.5           If
any term, provision, covenant or restriction of this Subscription is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction.

 

[Remainder of page intentionally
left blank]

 

    	11 

     

    

  

H/CELL ENERGY CORPORATION

PURCHASER SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT

 

IN WITNESS WHEREOF,
the Purchaser has executed this Subscription Agreement as of the date written below.

 

	No. of Shares to be Purchased	 	 
	 	 	 
	Total Share Purchase Price ($) (at $0.50 per Share)	 	$	 

 

	The Shares are to be issued in	 	 
	(check one box):	 	 
	 	 	Print Name of Individual Subscriber
	 	 	 	 
	 ̈	Individual name	 	 
	 	 	 	Print Name of Joint Subscriber (if applicable)
	 ̈	Joint tenants with rights of survivorship	 	 
	 	 	 	 
	 ̈	Tenants in entirety	 	Signature of Subscriber
	 	 	 	 
	 ̈	Corporation (an officer must sign)	 	 
	 	 	 	Signature of Joint Subscriber
	 ̈	Partnership (all general partners must sign)	 	 
	 	 	 
	Address:	 	 	Social Security Number(s) of Subscriber(s)
	 	 	 	 
	 	 	 	 
	Telephone: _____________________________	 	Print Name of Corporation, Limited Liability Company, Trust or other institution investor (including IRAs)
	 	 	 
	E-mail Address: _________________________	 	 
	 	 	Signature for Corporation, Limited Liability Company, Trust or other institution investor (including IRAs)
	 	 	 
	 	 	By: _______________________________
	 	 	 
	 	 	Title: ______________________________
	 	 	 
	 	 	 
	 	 	Tax Identification Number of Corporation, Limited Liability Company, Trust or other institution investor (including IRAs)

 

[Company signature page follows]

 

     

     

    

 

H/CELL ENERGY CORPORATION

COMPANY SIGNATURE PAGE TO

SUBSCRIPTION AGREEMENT

 

The Company’s signature below
constitutes execution of the Subscription Agreement. 

 

ACCEPTED AND AGREED TO

 

this ___ day of ___________, 2016.

 

	H/CELL ENERGY CORPORATION	 
	 	 
	By:	 	 
	 	Name: Andrew Hidalgo	 
	 	Title: Chief Executive Officer	 

 

     

     

    

  

EXHIBIT A - ACCREDITED
INVESTOR QUESTIONNAIRE

 

The undersigned Purchaser
is an “accredited investor” as that term is defined in Regulation D promulgated under the Securities Act by virtue
of being (initial all applicable responses):

 

	—	A small business investment company licensed by the U.S. Small Business Administration under the Small Business Investment Company Act of 1958,
	 	 
	—	A business development company as defined in the Investment Company Act of 1940,
	 	 
	—	A national or state-chartered commercial bank, whether acting in an  individual or fiduciary capacity,
	 	 
	—	An insurance company as defined in Section 2(13) of the Securities Act,
	 	 
	—	An investment company registered under the Investment Company Act of 1940,
	 	 
	—	An employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, where the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, insurance company, or registered investment advisor, or an employee benefit plan which has total assets in excess of $5,000,000,
	 	 
	—	A private business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940,
	 	 
	—	An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation or a partnership with total assets in excess of $5,000,000,
	 	 
	—	A natural person whose individual net worth, or joint net worth with that person's spouse, at the time of purchase exceeds $1,000,000.  For purposes of this Exhibit A, “net worth” means the excess of total assets at fair market value over total liabilities. For purposes of calculating net worth under this section, (i) the primary residence shall not be included as an asset, (ii) to the extent that the indebtedness that is secured by the primary residence is in excess of the fair market value of the primary residence, the excess amount shall be included as a liability, and (iii) if the amount of outstanding indebtedness that is secured by the primary residence exceeds the amount outstanding 60 days prior to the execution of this questionnaire, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability.
	 	 
	—	Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Section 506(b)(2)(ii) of Regulation D,
	 	 
	—	A natural person who had an individual income in excess of $200,000 in each of the two most recent calendar years, and has a reasonable expectation of reaching the same income level in the current calendar year.  For purposes of this Exhibit A, “income” means annual adjusted gross income, as reported for federal income tax purposes, plus (i) the amount of any tax-exempt interest income received; (ii) the amount of losses claimed as a limited partner in a limited partnership; (iii) any deduction claimed for depletion; (iv) amounts contributed to an IRA or Keogh retirement plan; (v) alimony paid; and (vi) any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202 of the Internal Revenue Code of 1986, as amended.
	 	 
	—	A corporation, partnership, trust or other legal entity (as opposed to a natural person) and all of such entity's equity owners fall into one or more of the categories enumerated above. (Note: additional documentation may be requested).

 

	 	 	 
	Name of Purchaser (Print)	 	Name of Joint Purchaser (if any) (Print)
	 	 	 
	 	 	 
	Signature of Purchaser	 	Signature of Joint Purchaser (if any)
	 	 	 
	 	 	 	 
	Capacity of Signatory (for entities)	 	Date

 

     

     

    

  

EXHIBIT B - WIRE INSTRUCTIONS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]